Products
Platform
Research
Market
Learn
Bal Pharma Ltd Financials Statements
Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios
Consolidate
Standalone
Total Qtr Revenue cr | 75.14 | 66.59 | 82.96 | 73.66 | 73.49 |
| Other Income Qtr Cr | 1.12 | 0.72 | 1.08 | 0.51 | -0.20 |
| Operating Revenues Qtr | 74.02 | 65.87 | 81.88 | 73.15 | 73.69 |
Loading chart... | |||||
Operating Expenses Qtr | 68.29 | 59.81 | 74.24 | 65.40 | 66.00 |
Operating Profit Qtr | 5.73 | 6.06 | 7.64 | 7.76 | 7.70 |
EBITDA Qtr Cr | 6.85 | 6.78 | 8.72 | 8.26 | 7.49 |
Depreciation Qtr | 2.27 | 2.52 | 2.18 | 2.69 | 2.48 |
Net Profit Qtr | 0.71 | 0.20 | 5.43 | 0.48 | 1.04 |
Basic EPS Qtr | 0.45 | 0.13 | 3.40 | 0.33 | 0.65 |
Open Demat Account
Open Demat Account